Assessment of QUAlity of life during long-term treatment of ToLVapatan in refractory heart failure.(AQUA-TLV)
Not Applicable
- Conditions
- heart failure
- Registration Number
- JPRN-UMIN000009604
- Lead Sponsor
- niversity of Tokyo Hospital
- Brief Summary
Tolvaptan arm had significantly improved quality of life compared with the control arm
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
1) serum sodium concentration over 145mEq/L 2) patients who were administered tolvaptan before admission 3) patients who had received mechanical devices 4) patients with acute coronary syndrome 5) patients with future surgical procedure 6) patients with anuria 7) patients unable to drink 8) patients unable to take medicine orally 9) patients with urine osmolality under 350 mOsm/
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method QOL score (Minnesota Living With Heart Failure Questionnaire)
- Secondary Outcome Measures
Name Time Method